Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
REGN: Regeneron Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
REGN
The Story
REGN
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+1.0% / yr
Operating margin
24.7%
ROIC
8895619.6%
Financially safe
Strong
Debt / equity
0.09×
Interest coverage
69.4×
Current ratio
3.57×
Valuation
Unrated
P/E ratio
18.2×
Dividend yield
0.5%
Regeneron Pharmaceuticals, Inc.
REGN
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Regeneron Pharmaceuticals, Inc.
REGN
NASDAQ
·
USD
·
Closed
$762.63
+3.29%
$762.63
+$24.29 (3.29%)
52W Range
79th
pctl
Volume
1.12×
avg
Mkt Cap
78.57B
USD
P/E
18.2
TTM
Div Yield
0.48%
ann
52W Range
79th
pctl
Volume
1.12×
avg
Market Cap
78.57B
USD
P/E Ratio
18.2
TTM
Div Yield
0.48%
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings